File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Caveolin-3 Peptide Protects Cardiomyocytes from Apoptotic Cell Death via Preserving Superoxide Dismutase Activity and Inhibiting Caspase-3 Activation under Hypoxia-reoxygenation

TitleCaveolin-3 Peptide Protects Cardiomyocytes from Apoptotic Cell Death via Preserving Superoxide Dismutase Activity and Inhibiting Caspase-3 Activation under Hypoxia-reoxygenation
Authors
KeywordsCaveolins
Oxidative stress
Cardiomyocytes
Hypoxia-reoxygenation
Apoptosis
Issue Date2011
PublisherNew World Publishing International. The Journal's web site is located at http://www.nwpii.com/ajbms.htm
Citation
American Journal of Biomedical Sciences, 2011, v. 3 n. 2, p. 126-144 How to Cite?
Abstract
Recent progress suggests that caveolins are cardiac protective molecules in regulating apoptotic cell death during myocardial ischemia-reperfusion injury. To understand the mechanisms of caveolins in cardiac protection, we investigated the expressions of caveolin-1(cav-1), caveolin-2 (cav-2) and caveolin-3 (cav-3) proteins in the isolated cultured hypoxia-reoxygenated cardiomyocytes. Neonatal rat cardiomyocytes were subjected to 4 h hypoxia and 24 h reoxygenation by exposed to 1% [O2] and replaced with normal air respectively. The expression of cav-3, instead of cav-1 and cav-2, was down-regulated by hypoxia-reoxygenation. Pre-treatments of superoxide dismutase and catalase (SOD/CAT) or peroxynitrite decomposition catalyst FeTMPyP prevented the down-regulation of cav-3. We then investigated the effects of extraneous free radicals on regulating the expression of cav-3 by incubating with xanthine/xanthine oxidase (X/XO), H2O2, 1-[N, N-di-(2-aminoethyl) amino] diazen-1-ium-1, 2-diolate (DETA/NO, NO donor) or 3-morpholinosydnonimine (SIN-1, peroxynitrite donor) respectively. Treatments of X/XO, H2O2, DETA/NO and SIN-1 significantly induced the down-regulation of cav-3 protein. The results indicate that the productions of free radicals contribute to the down-regulation of cav-3 protein in the hypoxia-reoxgenated cardiomyocytes. Moreover, our data showed that cav-3 peptide significantly enhanced the expression and the activity of SOD, inhibited O2.- production and caspase 3 activity, and reduced the rates of early and late apoptotic cell death, whereas cav-1 peptide had no effect on SOD, but slightly reduced O2.- production and decreased the rates of apoptotic cell death in the hypoxia-reoxygenated cardiomyocytes. Taken together, we conclude that caveolin-1 and caveolin-3 could ameliorate free radicals-induced oxidative injury via diverse mechanisms in hypoxia-reoxygenated cardiomyocytes.
DescriptionOpen Access Journal
Persistent Identifierhttp://hdl.handle.net/10722/138121
ISSN

 

DC FieldValueLanguage
dc.contributor.authorShen, Jen_US
dc.contributor.authorLee, WSen_US
dc.contributor.authorChen, Jen_US
dc.contributor.authorYang, Den_US
dc.date.accessioned2011-08-26T14:41:03Z-
dc.date.available2011-08-26T14:41:03Z-
dc.date.issued2011en_US
dc.identifier.citationAmerican Journal of Biomedical Sciences, 2011, v. 3 n. 2, p. 126-144en_US
dc.identifier.issn1937-9080en_US
dc.identifier.urihttp://hdl.handle.net/10722/138121-
dc.descriptionOpen Access Journal-
dc.description.abstractRecent progress suggests that caveolins are cardiac protective molecules in regulating apoptotic cell death during myocardial ischemia-reperfusion injury. To understand the mechanisms of caveolins in cardiac protection, we investigated the expressions of caveolin-1(cav-1), caveolin-2 (cav-2) and caveolin-3 (cav-3) proteins in the isolated cultured hypoxia-reoxygenated cardiomyocytes. Neonatal rat cardiomyocytes were subjected to 4 h hypoxia and 24 h reoxygenation by exposed to 1% [O2] and replaced with normal air respectively. The expression of cav-3, instead of cav-1 and cav-2, was down-regulated by hypoxia-reoxygenation. Pre-treatments of superoxide dismutase and catalase (SOD/CAT) or peroxynitrite decomposition catalyst FeTMPyP prevented the down-regulation of cav-3. We then investigated the effects of extraneous free radicals on regulating the expression of cav-3 by incubating with xanthine/xanthine oxidase (X/XO), H2O2, 1-[N, N-di-(2-aminoethyl) amino] diazen-1-ium-1, 2-diolate (DETA/NO, NO donor) or 3-morpholinosydnonimine (SIN-1, peroxynitrite donor) respectively. Treatments of X/XO, H2O2, DETA/NO and SIN-1 significantly induced the down-regulation of cav-3 protein. The results indicate that the productions of free radicals contribute to the down-regulation of cav-3 protein in the hypoxia-reoxgenated cardiomyocytes. Moreover, our data showed that cav-3 peptide significantly enhanced the expression and the activity of SOD, inhibited O2.- production and caspase 3 activity, and reduced the rates of early and late apoptotic cell death, whereas cav-1 peptide had no effect on SOD, but slightly reduced O2.- production and decreased the rates of apoptotic cell death in the hypoxia-reoxygenated cardiomyocytes. Taken together, we conclude that caveolin-1 and caveolin-3 could ameliorate free radicals-induced oxidative injury via diverse mechanisms in hypoxia-reoxygenated cardiomyocytes.-
dc.languageengen_US
dc.publisherNew World Publishing International. The Journal's web site is located at http://www.nwpii.com/ajbms.htm-
dc.relation.ispartofAmerican Journal of Biomedical Sciencesen_US
dc.subjectCaveolins-
dc.subjectOxidative stress-
dc.subjectCardiomyocytes-
dc.subjectHypoxia-reoxygenation-
dc.subjectApoptosis-
dc.titleCaveolin-3 Peptide Protects Cardiomyocytes from Apoptotic Cell Death via Preserving Superoxide Dismutase Activity and Inhibiting Caspase-3 Activation under Hypoxia-reoxygenationen_US
dc.typeArticleen_US
dc.identifier.emailShen, J: shenjg@hku.hken_US
dc.identifier.emailLee, WS: waisin@hku.hken_US
dc.identifier.emailChen, J: abchen@hku.hken_US
dc.identifier.authorityShen, J=rp00487en_US
dc.identifier.authorityChen, J=rp01316en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.5099/aj110200126-
dc.identifier.hkuros189750en_US
dc.identifier.volume3en_US
dc.identifier.issue2en_US
dc.identifier.spage126en_US
dc.identifier.epage144en_US
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats